| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/26/1996 | US5502068 Cyclopropylpyrroloindole-oligopeptide anticancer agents |
| 03/26/1996 | US5502046 11β-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agents |
| 03/26/1996 | US5502037 Antitumor agents for procytotoxic drugs |
| 03/26/1996 | US5502032 Peptides, the preparation and use thereof |
| 03/26/1996 | US5501969 Bone disorders, antitumor |
| 03/26/1996 | US5501856 Controlled-release pharmaceutical preparation for intra-ocular implant |
| 03/26/1996 | CA1338184C Bu-3862t antitumor antibiotic |
| 03/21/1996 | WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases |
| 03/21/1996 | WO1996008563A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 03/21/1996 | WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 03/21/1996 | WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 03/21/1996 | WO1996008503A1 Intermediates for dinucleotide and oligonucleotide analogues |
| 03/21/1996 | WO1996008490A1 NOVEL MELATONIN AGONIST β-CARBOLINE DERIVATIVES AND ANALOGS WITH A NAPHTHALENIC STRUCTURE, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS |
| 03/21/1996 | WO1996008256A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 03/21/1996 | WO1996008240A1 Use of aromatic halides for treating mammalian cell proliferation |
| 03/21/1996 | CA2199820A1 Modulation of drug radiation resistant genes |
| 03/21/1996 | CA2199719A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 03/21/1996 | CA2198900A1 Intermediates for dinucleotide and oligonucleotide analogues |
| 03/21/1996 | CA2158724A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid |
| 03/20/1996 | EP0702084A1 Recombinant retroviruses |
| 03/20/1996 | EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists |
| 03/20/1996 | EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent |
| 03/20/1996 | EP0701818A2 Therapeutic methods using catalytic antibodies |
| 03/20/1996 | EP0701564A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
| 03/20/1996 | EP0701559A1 Cephalostatin analogues and their use as anti-tumour agents |
| 03/20/1996 | EP0701557A1 Lavendamycin analogs, their use and preparation |
| 03/20/1996 | EP0701440A1 Tri(platinum) complexes |
| 03/20/1996 | EP0701435A1 Compositions for boron neutron capture therapy and methods thereof |
| 03/20/1996 | EP0690867A4 Taxanes having furyl or thienyl substituted side-chain |
| 03/20/1996 | EP0690711A4 Taxanes having an amino substituted side-chain |
| 03/20/1996 | EP0688212A4 C9 taxane derivatives and pharmaceutical compositions containing them |
| 03/20/1996 | CN1118766A A hexagonal molecular structure water manufacturing apparatus and a method thereof |
| 03/20/1996 | CA2158076A1 Antitumor antibiotic compounds; hayumicins and analogs thereof |
| 03/19/1996 | US5500359 Fermentation, antitumor agents |
| 03/19/1996 | CA1338169C Compounds wf 2015 a and b, production thereof and use thereof |
| 03/14/1996 | WO1996007747A1 Retroviral vector hybrids and the use thereof for gene transfer |
| 03/14/1996 | WO1996007668A1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes |
| 03/14/1996 | WO1996007667A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids |
| 03/14/1996 | WO1996007658A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 03/14/1996 | WO1996007657A1 Pyrimido[5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 03/14/1996 | WO1996007435A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 03/14/1996 | WO1996007433A1 Gene therapy drug for cancer, medicinal composition, and therapeutic method |
| 03/14/1996 | WO1996007422A1 Use of il-4 for potentiation of chemotherapeutic agents |
| 03/14/1996 | WO1996007413A1 Compounds and methods for the treatment of cancer |
| 03/14/1996 | WO1996007322A1 Method of sensitizing tumor cells with adenovirus e1a |
| 03/14/1996 | WO1996006168A3 Retinoblastoma protein-interacting zinc finger proteins |
| 03/14/1996 | WO1996002556A3 Oligonucleotides with anti-mdr-1 gene activity |
| 03/14/1996 | CA2199265A1 Method of sensitizing tumor cells with adenovirus e1a |
| 03/14/1996 | CA2199262A1 Use of il-4 for potentiation of chemotherapeutic agents |
| 03/14/1996 | CA2197788A1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes |
| 03/14/1996 | CA2197785A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids |
| 03/13/1996 | EP0700914A1 Camptothecin derivatives, preparations thereof and antitumor agents |
| 03/13/1996 | EP0700904A1 Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicaments containing them as well as intermediates for their preparation |
| 03/13/1996 | EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them |
| 03/13/1996 | EP0700444A1 Immunotoxins comprising gelonin and an antibody |
| 03/13/1996 | EP0700430A1 Methods for selectively stimulating proliferation of t cells |
| 03/13/1996 | EP0700388A1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors |
| 03/13/1996 | EP0700376A1 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents |
| 03/13/1996 | EP0700305A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 03/13/1996 | EP0700304A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 03/13/1996 | EP0700301A1 Peptides and compounds that bind to elam-1 |
| 03/13/1996 | EP0700287A1 Arylating medicaments |
| 03/13/1996 | EP0690841A4 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 03/13/1996 | EP0665746A4 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGF-g(a)PE 40?ab. |
| 03/13/1996 | EP0491007B1 Structural alterations of the egf receptor gene in human gliomas |
| 03/13/1996 | EP0438497B1 Vasopermeability-enhancing conjugates |
| 03/13/1996 | EP0436598B1 Cell sorting technique and applications thereof |
| 03/13/1996 | EP0436545B1 Therapeutic methods using catalytic antibodies |
| 03/13/1996 | CN1118347A Benzotoudened 5-ringneterocycl, preparation and phamaceutical and diagnostic use of same |
| 03/13/1996 | CN1118252A Stabized solutions of platinum (II) antitumor agents |
| 03/13/1996 | CN1031242C 化妆品组合物 Cosmetic composition |
| 03/12/1996 | US5498780 Platinum complex and malignant tumor treating drug containing the same |
| 03/12/1996 | US5498697 Protein possessing metastasis-inhibitory activity |
| 03/12/1996 | US5498611 Ellipticine compounds |
| 03/12/1996 | US5498608 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 03/12/1996 | US5498599 Methods for stimulating platelet production |
| 03/07/1996 | WO1996006943A1 Cell cycle regulated repressor and dna element |
| 03/07/1996 | WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 03/07/1996 | WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/07/1996 | WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 03/07/1996 | WO1996006937A1 Improvements in production of proteins in host cells |
| 03/07/1996 | WO1996006867A1 Method for controlling o-desulfation of heparin and compositions produced thereby |
| 03/07/1996 | WO1996006863A1 Agents for inducing apoptosis and applications of said agents in therapy |
| 03/07/1996 | WO1996006620A2 Lipid analogs for treating viral infections |
| 03/07/1996 | WO1996006528A1 Ionene polymers containing biologically-active anions |
| 03/07/1996 | WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy |
| 03/07/1996 | CA2198908A1 Method for controlling o-desulfation of heparin and compositions produced thereby |
| 03/07/1996 | CA2198891A1 Genetically modified t cells |
| 03/07/1996 | CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 03/07/1996 | CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound |
| 03/07/1996 | CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 03/07/1996 | CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 03/07/1996 | CA2198345A1 Improvements in production of proteins in host cells |
| 03/07/1996 | CA2198080A1 Cell cycle regulated repressor and dna element |
| 03/06/1996 | EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4 |
| 03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
| 03/06/1996 | EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
| 03/06/1996 | EP0699679A1 Tetrahydropyranyl compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/06/1996 | EP0699663A1 Alkyl-benzoylguanidine derivatives |
| 03/06/1996 | EP0699442A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |